Management of Autonomic Dysfunction with Hypertension in Traumatic Brain Injury

Immediate Blood Pressure Management

The American College of Surgeons recommends maintaining systolic blood pressure >110 mmHg in TBI patients to prevent mortality, as mortality increases markedly when SBP drops below this threshold 1
The American Heart Association suggests using vasopressor drugs, such as phenylephrine or norepinephrine, for rapid correction of hypotension in TBI patients, as decreasing sedatives or increasing fluids have delayed hemodynamic effects 1, 2, 3

The Brain Trauma Foundation recommends targeting cerebral perfusion pressure (CPP) of 60-70 mmHg throughout treatment, as CPP <60 mmHg is associated with poor neurological outcomes 4, 5
The Neurocritical Care Society suggests using hypertonic saline as a superior alternative to mannitol in the presence of hypotension or hypovolemia, as it increases blood pressure and has minimal diuretic effect 4, 6
The American Academy of Neurology recommends 3% hypertonic saline dosing: 5 mL/kg IV over 15 minutes, followed by continuous infusion at 1 mL/kg per hour, with a target serum sodium of 150-155 mEq/L 4, 6

The Society of Critical Care Medicine recommends maintaining PaCO2 at 4.5-5.0 kPa (34-38 mmHg) through controlled ventilation with end-tidal CO2 monitoring, to prevent cerebral vasoconstriction and worsen ischemic injury 1, 2

The American Society of Anesthesiologists suggests using continuous sedation rather than boluses to prevent hemodynamic instability, and avoiding hypotensive agents for sedation induction 1, 3

The Neurocritical Care Society recommends ICP monitoring in patients with GCS ≤8 and abnormal CT scan, and serum sodium, chloride, and osmolality every 4-6 hours if using hyperosmolar therapy 5, 6

The American College of Surgeons advises against treating compensatory hypertension aggressively in acute TBI, as it may be maintaining cerebral perfusion 1, 5
The Brain Trauma Foundation recommends avoiding serum sodium levels exceeding 155 mEq/L on maintenance hypertonic saline infusion, and continuing electrolyte monitoring after the first 24 hours of hyperosmolar therapy 4, 6